Commuting expenses are on employees' minds, and with more employees returning to the office, commuter benefits can ease the transition Commuting expenses are on employees' minds, and with more employees returning to the office, commuter benefits can ease the transition ...

Santiment data shows 261 new 100,000+ XRP wallets in 10 weeks, signalling rising confidence. Crypto trader predicts a breakout which could potentially lead to a 26% price rally. Get real-time earnings alerts before the market moves and access expert analysis that uncovers hidden opportunities in ...

ATHENS, Greece, Feb. 20, 2025 ( GLOBE NEWSWIRE ) -- EuroDry Ltd. ( NASDAQ: EDRY, the "Company" or "EuroDry" ) , an owner and operator of drybulk vessels and provider of seaborne transportation for drybulk cargoes, announced today that it will release its financial results for the fourth quarter ...

Strong future foundations ...

ATHENS, Greece, Feb. 20, 2025 ( GLOBE NEWSWIRE ) -- Performance Shipping Inc. ( NASDAQ: PSHG ) ( "we" or the "Company" ) , a global shipping company specializing in the ownership of tanker vessels, today reported net income of $9.7 million and net income attributable to common stockholders of ...

The market's underestimating how well each of these companies should be able to capitalize on their opportunities.

Madrid, Spain and Tel Aviv, Israel, February 20, 2025 - ( GLOBE NEWSWIRE ) Codere Online ( Nasdaq: CDRO / CDROW, the "Company" ) , a leading online gaming operator in Spain and Latin America, has released its preliminary unaudited4 financial results for the quarter and year ended December 31, ...

NORCROSS, Ga., Feb. 20, 2025 ( GLOBE NEWSWIRE ) -- CoreCard Corporation ( NYSE: CCRD ) ( "CoreCard" or "the Company" ) , the leading provider of innovative credit technology solutions and processing services to the financial technology and services market, announced today its financial results ...

CAMBRIDGE, Mass., Feb. 20, 2025 ( GLOBE NEWSWIRE ) -- Intellia Therapeutics, Inc. ( NASDAQ:NTLA ) , a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, will present its fourth quarter and full-year 2024 financial results and operational ...

- As of February 17, 2025, 1,028 unique patient prescriptions for Attruby™ have been written by 516 unique prescribers since FDA approval ...